Sign in

CIK 0001585364

  • Large accelerated filer

PERRIGO Co plc

Sign in to watch
Ticker
PRGO
Exchange
NYSE
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
Ireland
Entity type
Operating
Phone
+1 269-673-8451
Business address
THE SHARP BUILDING, HOGAN PLACE, DUBLIN 2, Ireland, D02 TY74
Former names
PERRIGO Co Ltd
  1. 4 Option exercise Director acquired 6,599 shares (option exercise)
  2. 4 Option exercise Director acquired 6,599 shares (option exercise)
  3. 4 Option exercise EVP, Chief Financial Officer acquired 3,963 shares (option exercise)
  4. 4 Open-market sale EVP and CIO sold 26,744 shares at an average $37.14 ($993,182)
  5. 4 Shares withheld for taxes EVP & CHRO gave up 5,209 shares (to pay taxes)
  6. 4 Open-market sale EVP, Gbl Ops & SC & CTO sold 3,954 shares at $36.73 ($145,232)
  7. 4 Grant or award EVP and CIO acquired 7,200 shares (grant or award)
  8. 4 Option exercise Director acquired 2,984 shares (option exercise)
  9. 4 Grant or award Executive VP, General Counsel acquired 14,503 shares (grant or award)
  10. 4 Grant or award EVP & President CSCA acquired 11,395 shares (grant or award)
  11. 4 Grant or award EVP, Chief Medical Officer acquired 6,008 shares (grant or award)
  12. 4 Grant or award CEO acquired 80,286 shares (grant or award)
  13. 4 Grant or award EVP, Chief Financial Officer acquired 19,422 shares (grant or award)
  14. 4 Grant or award EVP & President CHCI acquired 14,503 shares (grant or award)
  15. 5 Insider Annual Insider Trading Report
  16. 4 Option exercise EVP & President CSCA acquired 4,297 shares (option exercise)
  17. 4 Open-market buy Executive VP, General Counsel bought 3,000 shares at $37.55 ($112,648)
  18. 4 Open-market buy Director bought 5,000 shares at $36.85 ($184,270)
  19. 4 Open-market buy Director bought 13,000 shares at $36.88 ($479,409)
  20. 4 Open-market buy EVP & President CHCI bought 3,655 shares at an average $37.10 ($135,599)

Page 13 of 41 · 805 filings